Artificial intelligence for cell-free systems

Cell-free systems let researchers carry out biological processes like protein synthesis and metabolism without using living cells. This approach has become increasingly important in synthetic biology because it allows for quick testing of ideas, running many experiments simultaneously, and maintaining tight control over reaction conditions. The main challenge has been figuring out how to optimize these systems, since there are so many variables that interact in unpredictable ways. Artificial intelligence (AI), including machine learning, deep learning, and generative models, has begun to tackle this problem by helping predict experimental outcomes, design new proteins, and find better reaction conditions. The discovery of antimicrobial peptides through deep learning and cell-free protein synthesis, along with a 34-fold increase in protein yield through buffer optimization guided by active learning, are some of the major advancements made possible. The use of Bayesian optimization and neural networks has helped to streamline metabolic pathway designing, enzyme engineering as well as yield prediction, which in turn has diversified the use of AI-driven approaches in biomanufacturing, pharmaceuticals, and diagnostics. In spite of hurdles like data requirements, model transferability, and scalability, the compatibility of AI and cell-free systems gives adequate probabilities of innovations like digital twins and self-driven biomanufacturing units. This chapter explores the integration of AI with cell-free systems, focusing on recent advances, industrial applications, and ending with future directions for synthetic biology.